Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma". (January 2022)

• Record Type: Journal Article
• Authors: Bateman, Eric D.; Khan, Asif H.; Xu, Yingxin; Guyot, Patricia; Chao, Jingdong; Kamat, Siddhesh; Rowe, Paul; Burnett, Heather; Msihid, Jerome; Weinreich, David; Pavord, Ian D.
• Is Part Of: Respiratory medicine. Volume 191(2022)
• Publication Date: 2022-01
• Subjects: Benralizumab -- Dupilumab -- Indirect treatment comparison -- Matching-adjusted indirect comparison -- Mepolizumab -- Severe eosinophilic asthma; Chest -- Diseases -- Periodicals; Chest -- Diseases -- Great Britain -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory Tract Diseases -- Periodicals; Appareil respiratoire -- Maladies -- Périodiques; Thorax -- Maladies -- Périodiques; Appareil respiratoire -- Maladies -- Traitement -- Périodiques; Electronic journals; 616.2
• DOI: 10.1016/j.rmed.2020.106088
• Languages: English
• ISSNs: 0954-6111